Anebulo Pharmaceuticals Inc 2024年度报告

Annual Report to Shareholders Anebulo Pharmaceuticals, Inc. 81,7('67$7(66(&85,7,(6$1'(;&+$1*(&200,66,21:$6+,1*721'& )250. 0DUN2QH ☒$118$/5(325738568$17726(&7,2125 G 2)7+(6(&85,7,(6(;&+$1*($&72) 75$16,7,215(325738568$17726(&7,2125 G 2)7+(6(&85,7,(6(;&+$1*($&72) 6HFXULWLHVUHJLVWHUHGSXUVXDQWWR6HFWLRQ E RIWKH$FW 6HFXULWLHVUHJLVWHUHGSXUVXDQWWR6HFWLRQ J RIWKH$FW1RQH ,QGLFDWHE\FKHFNPDUNLIWKH5HJLVWUDQWLVDZHOONQRZQVHDVRQHGLVVXHUDVGHILQHGLQ5XOHRIWKH6HFXULWLHV$FW<(6☐12☒ ,QGLFDWHE\FKHFNPDUNLIWKH5HJLVWUDQWLVQRWUHTXLUHGWRILOHUHSRUWVSXUVXDQWWR6HFWLRQRU G RIWKH$FW<(6☐12☒ ,QGLFDWHE\FKHFNPDUNZKHWKHUWKH5HJLVWUDQW  KDVILOHGDOOUHSRUWVUHTXLUHGWREHILOHGE\6HFWLRQRU G RIWKH6HFXULWLHV([FKDQJH$FWRIGXULQJWKHSUHFHGLQJPRQWKV RUIRUVXFKVKRUWHUSHULRGWKDWWKH5HJLVWUDQWZDVUHTXLUHGWRILOHVXFKUHSRUWV DQG  KDVEHHQVXEMHFWWRVXFKILOLQJUHTXLUHPHQWVIRUWKHSDVWGD\V